As a child we always asked ourselves: What if every person on earth would donate as little as 1 Cent? How much money could we raise? With this question at the back of our minds we want to demonstrate how the power of easily donating 1 Cent via the internet could mobilize the masses.Have a look at the OneCentInitiative and imagine how you can be part of a big change.
As the proud son of a breast cancer survivor, Scott Gentle was honored to narrate this video for the Susan G. Komen Foundation's "The Power of 1" initiative for 2013.
Komen's Global Movement
Every 74 seconds, someone dies from breast cancer, and, too often, where you live determines whether you live. Worldwide, breast cancer is the most frequently diagnosed cancer in women — every 19 seconds, a woman is diagnosed with breast cancer. In the developing world, breast cancer cases in younger women (ages 15-49 years) now make up 44.1% of the overall number of cases.
The burden of cervical cancer is shifting to the developing world and more women are being diagnosed with cervical cancer during their reproductive years. Furthermore, HIV-positive women are at least five times more likely to be diagnosed with cervical cancer than uninfected women. In 2010, 454,000 women developed cervical cancer globally, and 76% of these cases occurred in developing countries. Cervical cancer is now the leading cause of cancer-related mortality among women in Africa.
Since its founding in 1982, Susan G. Komen — the world’s largest grassroots breast cancer organization — has played a critical role in nearly every major advance in the fight against breast cancer. Heeding the growing demands to address the looming global "cancer tsunami," we have reaffirmed our commitment to further our international impact through strategic public-private partnerships aimed at strengthening national capacities to deliver services throughout the continuum of cancer care, including education and awareness, vaccines, screening and treatment that are urgently needed to address the growing global cancer epidemic.
In partnership with Merck, Komen hopes to create a global movement that leads to the end of cervical cancer and the significant down-staging of breast cancer.